Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:OCI - NL0010558797 - Common Stock

3.05 EUR
-0.08 (-2.56%)
Last: 1/6/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to OCI. OCI was compared to 73 industry peers in the Chemicals industry. While OCI is still in line with the averages on profitability rating, there are concerns on its financial health. OCI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OCI had positive earnings in the past year.
OCI had a negative operating cash flow in the past year.
In multiple years OCI reported negative net income over the last 5 years.
In the past 5 years OCI always reported a positive cash flow from operatings.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

The Return On Assets of OCI (140.77%) is better than 100.00% of its industry peers.
OCI's Return On Equity of 267.11% is amongst the best of the industry. OCI outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 140.77%
ROE 267.11%
ROIC N/A
ROA(3y)41.09%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

OCI's Profit Margin of 510.61% is amongst the best of the industry. OCI outperforms 100.00% of its industry peers.
OCI's Profit Margin has improved in the last couple of years.
OCI has a worse Gross Margin (0.21%) than 89.04% of its industry peers.
OCI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 510.61%
GM 0.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

3

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OCI remains at a similar level compared to 1 year ago.
The number of shares outstanding for OCI has been increased compared to 5 years ago.
The debt/assets ratio for OCI has been reduced compared to a year ago.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

OCI has an Altman-Z score of 0.88. This is a bad value and indicates that OCI is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.88, OCI is doing worse than 82.19% of the companies in the same industry.
A Debt/Equity ratio of 0.05 indicates that OCI is not too dependend on debt financing.
The Debt to Equity ratio of OCI (0.05) is better than 90.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.88
ROIC/WACCN/A
WACC8.08%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

OCI has a Current Ratio of 1.65. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.65, OCI is in line with its industry, outperforming 49.32% of the companies in the same industry.
OCI has a Quick Ratio of 1.60. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI's Quick ratio of 1.60 is fine compared to the rest of the industry. OCI outperforms 73.97% of its industry peers.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.6
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

OCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1375.14%, which is quite impressive.
Measured over the past years, OCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 105.88% on average per year.
OCI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.00%.
OCI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.30% yearly.
EPS 1Y (TTM)1375.14%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%

3.2 Future

Based on estimates for the next years, OCI will show a very strong growth in Earnings Per Share. The EPS will grow by 60.21% on average per year.
The Revenue is expected to decrease by -14.70% on average over the next years. This is quite bad
EPS Next Y698.37%
EPS Next 2Y176.13%
EPS Next 3Y37.79%
EPS Next 5Y60.21%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.15, the valuation of OCI can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of OCI indicates a rather cheap valuation: OCI is cheaper than 100.00% of the companies listed in the same industry.
OCI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.17.
The Price/Forward Earnings ratio is 9.64, which indicates a very decent valuation of OCI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of OCI indicates a rather cheap valuation: OCI is cheaper than 90.41% of the companies listed in the same industry.
OCI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.15
Fwd PE 9.64
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as OCI's earnings are expected to grow with 37.79% in the coming years.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y176.13%
EPS Next 3Y37.79%

0

5. Dividend

5.1 Amount

No dividends for OCI!.
Industry RankSector Rank
Dividend Yield 0%

OCI NV

AMS:OCI (1/6/2026, 7:00:00 PM)

3.05

-0.08 (-2.56%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-12 2026-03-12/amc
Inst Owners41.28%
Inst Owner ChangeN/A
Ins Owners8.46%
Ins Owner ChangeN/A
Market Cap644.65M
Revenue(TTM)975.10M
Net Income(TTM)4.98B
Analysts70
Price Target3.89 (27.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend12.96
Dividend Growth(5Y)N/A
DP84.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-35.82%
PT rev (3m)-46.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)14.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-3.34%
Valuation
Industry RankSector Rank
PE 0.15
Fwd PE 9.64
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)20.08
EY658.36%
EPS(NY)0.32
Fwd EY10.38%
FCF(TTM)-1.06
FCFYN/A
OCF(TTM)-1.64
OCFYN/A
SpS3.93
BVpS7.5
TBVpS7.41
PEG (NY)0
PEG (5Y)N/A
Graham Number58.22
Profitability
Industry RankSector Rank
ROA 140.77%
ROE 267.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 510.61%
GM 0.21%
FCFM N/A
ROA(3y)41.09%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 244.07%
Cap/Sales 14.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.6
Altman-Z 0.88
F-Score4
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)137.5%
Cap/Depr(5y)96.97%
Cap/Sales(3y)24.97%
Cap/Sales(5y)17.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1375.14%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
EPS Next Y698.37%
EPS Next 2Y176.13%
EPS Next 3Y37.79%
EPS Next 5Y60.21%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%
EBIT growth 1Y44.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.34%
EBIT Next 3Y-24.1%
EBIT Next 5Y-4.61%
FCF growth 1Y-119.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.1%
OCF growth 3Y-68.92%
OCF growth 5Y-27.41%

OCI NV / OCI.AS FAQ

What is the ChartMill fundamental rating of OCI NV (OCI.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OCI.AS.


Can you provide the valuation status for OCI NV?

ChartMill assigns a valuation rating of 6 / 10 to OCI NV (OCI.AS). This can be considered as Fairly Valued.


What is the profitability of OCI stock?

OCI NV (OCI.AS) has a profitability rating of 4 / 10.


Can you provide the financial health for OCI stock?

The financial health rating of OCI NV (OCI.AS) is 3 / 10.


How sustainable is the dividend of OCI NV (OCI.AS) stock?

The dividend rating of OCI NV (OCI.AS) is 0 / 10 and the dividend payout ratio is 84.62%.